PUMA BIOTECHNOLOGY, INC. (PBYI) › Operating Cash FlowPUMA BIOTECHNOLOGY, INC. (PBYI) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: -$1.82M2012: -$44.01M2016: -$141.69M2017: -$172.47M2018: -$24.11M2019: $22.38M2020: $773.0K2021: $20.65M2022: -$15.83M2023: $27.01M2024: $38.92M2025: $41.80M$41.80M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$41.80M+7.4%2024$38.92M+44.1%2023$27.01M+270.7%2022-$15.83M-176.6%2021$20.65M+2571.4%2020$773.0K-96.5%2019$22.38M+192.8%2018-$24.11M+86.0%2017-$172.47M-21.7%2016-$141.69M—2012-$44.01M-2312.9%2011-$1.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share